Atezolizumab-Induced Stevens-Johnson Syndrome in a Patient with Non-Small Cell Lung Carcinoma

• Main Authors: Phatcharawat Chirasuthat (Author), Pamela Chayavichitsilp (Author)
• פורמט: ספר
• יצא לאור: Karger Publishers, 2018-08-01T00:00:00Z.
• נושאים: article
• גישה מקוונת: Connect to this object online.

Atezolizumab is a humanized anti-PD-L1 immune checkpoint antibody that is currently used in many kinds of advanced carcinoma including metastatic non-small cell lung cancer. The cutaneous side effect profile reported only 20% of the patients which had only mild maculopapular rash that required no tr...